Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Exact Sciences plans to introduce the Cologuard Plus™ test in 2025, building on a decade of patient impact.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
How one revolutionary test could change the health of millions.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
Several Exact Sciences initiatives address disparities in cancer outcomes among U.S. Latinos.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
Colorectal cancer is treatable in about 90% of cases1 when caught in early stages. Still, an estimated 60 million people ages 45-85 remain unscreened.2 At Exact Sciences, we want to change that.
To improve colorectal cancer screening completion, it’s important that patients understand their options and feel comfortable with the testing process. Healthcare providers can help to encourage screening adherence by engaging in conversation with their patients and making testing decisions together.
At the 2023 ASCO Gastrointestinal Cancers Symposium, new data supported the importance of patient involvement in the colorectal cancer screening process. To better understand what this means for healthcare providers and their patients, we sat down with Shama Alam, Senior Manager of Evidence Generation and Guidelines Strategy, Screening Medical Affairs at Exact Sciences to learn more.
Exact Sciences
Read more »
Emily Pinto